Clinical Studies & Research
Aesthetic Solutions is an active research center, partnering with pharmaceutical and medical device manufacturers to bring the latest treatments to our patients and advance safe, effective aesthetic treatments.
Nasolabial Folds Filler 2102-51
Status: In Progress
We have completed enrollment for this study evaluating the effectiveness of a filler in the nasolabial folds when injected with a needle and cannula.
Temple Filler 2005-50
Status: In Progress
We have finished enrollment for this study evaluating the effectiveness of a filler when used in the temples. Dr. Cox is serving as the principal investigator.
Crow’s Feet Neuromodulator 2002-49
Status: Completed
Dr. Cox has completed work as the principal investigator for this study evaluating the effectiveness of a new neuromodulator when used in the crow’s feet (around the eyes) area. This study began in February 2020 and ended in March 2021. We hope to see this product on the market soon!
Glabellar Neuromodulator 1904-48
Status: Completed
Dr. Cox has completed work on this study servings as the principal investigator. This study evaluated the effectiveness of a new neuromodulator when used in the glabellar (between the brows) area.
Body Contouring 1811-47
Status: Completed
Dr. Cox completed work as the principal investigator in this study “A Feasibility Study to Evaluate Electromagnetic Muscle Stimulation and CoolSculpting for Abdominal Contouring”. The study began in November 2018 and ended in April 2019.
Glabellar Neuromodulator 1811-46
Status: Completed
Dr. Cox completed work for this study “A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines” serving as the principal investigator.
Jawline Filler 1811-45
Status: Completed
Dr. Cox has completed work as the principal investigator for this multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of JUVÉDERM VOLUX™ XC injectable gel for restoring jawline definition. This study began in November 2018 and ended in April 2021.
Cheek Filler 1802-44
Status: Completed
Dr. Cox completed work as the principal investigator on this multicenter, single-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM
VOLUMA® XC injectable gel for cheek augmentation using a cannula. Dr. Cox has long been an advocate for the safety and effectiveness of injecting with the use of a cannula rather than just a needle in the mid-face. This study began in February of 2018 and finished in October of 2018.
Under Eye Filler 1802-43
Status: Completed
Dr. Cox has completed work as principal investigator for this study “A Multicenter, Single-Blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA for Correction of Infraorbital Hollowing.” Dr. Cox was pleased with the beautiful, natural results achieved. This study began in February 2018 and ended in October 2019.
Lip Filler Study 1711-42
Status: Completed
Dr. Cox has completed work as principal investigator for this study “A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane Kysse versus a Control in the Augmentation of Soft Tissue Fullness of the Lip.” Dr. Cox found this new product to be unique and effective, and we’re excited to now have Restylane Kysse as a treatment option for patients. This study began in November 2017 and ended in June of 2019.